Integration of immunotherapy into adjuvant therapy for resected non-small-cell lung cancer: ALCHEMIST chemo-IO (ACCIO)

Authors

Jacob M Sands, Dana-Farber Cancer Institute
Ramaswamy Govindan, Washington University School of Medicine in St. Louis
Jhanelle Gray, Washington University School of Medicine in St. Louis
et al

Journal

Immunotherapy

Publication Date

6-1-2021

Volume

13

Issue

9

First Page

727

Last Page

734

Document Type

Open Access Publication

DOI

10.2217/imt-2021-0019

Rights and Permissions

Sands JM, Mandrekar SJ, Kozono D, Oxnard GR, Hillman SL, Wigle DA, Govindan R, Carlisle J, Gray J, Salama JK, Raez L, Ganti A, Foster N, Malik S, Bradley J, Kelly K, Ramalingam SS, Stinchcombe TE. Integration of immunotherapy into adjuvant therapy for resected non-small-cell lung cancer: ALCHEMIST chemo-IO (ACCIO). Immunotherapy. 2021 Jun;13(9):727-734. doi: 10.2217/imt-2021-0019. This work is licensed under the Attribution-NonCommercial-NoDerivatives 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/. For full bibliographic citation, please refer to the version available at www.futuremedicine.com.

Recommended Citation

Sands, Jacob M; Govindan, Ramaswamy; Gray, Jhanelle; and et al, "Integration of immunotherapy into adjuvant therapy for resected non-small-cell lung cancer: ALCHEMIST chemo-IO (ACCIO)." Immunotherapy. 13, 9. 727 - 734. (2021).
https://digitalcommons.wustl.edu/oa_4/411